Morning Briefing
Summaries of health policy coverage from major news organizations
Senate Finance Committee Probing Prices For Hepatitis C Drug
Sens. Ron Wyden, D-Ore., and Charles Grassley, R-Iowa, send letter to the drug's maker requesting information about how it set the price, which runs about $84,000 for a standard three-month regimen.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
